246710.KQ KOE
T&R Biofab Co., Ltd.
1W: +1.3%
1M: +2.0%
3M: +6.4%
YTD: -29.7%
1Y: -23.4%
3Y: -79.2%
5Y: -89.2%
₩2,320.00 ($1.72)
+20.00 (+0.87%)
Weekly Expected Move ±6.0%
₩2040
₩2180
₩2320
₩2460
₩2600
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩110.6B ($82.1M)
52W Range1127-11800
Volume131,816
Avg Volume248,240
Beta0.46
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWonsoo Yun
Employees97
SectorHealthcare
IndustryMedical - Specialties
IPO Date2018-11-28
Websitetnrbiofab.com
96, Mayu-ro
Siheung-Si, GY 15111
KR
Siheung-Si, GY 15111
KR
82 3 1431 3344
About T&R Biofab Co., Ltd.
T&R Biofab Co., Ltd. is dedicated to advancing medical technology through the development of innovative devices designed for tissue regeneration and transplantation procedures. Their work primarily serves the fields of orthopedics, plastic surgery, and dentistry. The company's product line encompasses custom patient implants, such as craniomaxillofacial and dental meshes. They also provide cutting-edge bioinks for 3D bioprinting and cell culture, alongside solutions for stem cell research and delivery, and specialized coatings for laboratory scaffolds and culture dishes. This enterprise was established in 2013 and operates from its base in Siheung-si, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found